Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

Related Articles by Review for PubMed (Select 23482643)

1.

Attenuation of live respiratory syncytial virus vaccines is associated with reductions in levels of nasal cytokines.

Karron RA, Thumar B, Schappell E, Buchholz UJ, Collins PL.

J Infect Dis. 2013 Jun 1;207(11):1773-9. doi: 10.1093/infdis/jit089. Epub 2013 Mar 12.

2.

The non-structural proteins of RSV: targeting interferon antagonists for vaccine development.

Teng MN.

Infect Disord Drug Targets. 2012 Apr;12(2):129-37. Review.

PMID:
22335499
3.

Immunopathology of RSV infection: prospects for developing vaccines without this complication.

van Drunen Littel-van den Hurk S, Mapletoft JW, Arsic N, Kovacs-Nolan J.

Rev Med Virol. 2007 Jan-Feb;17(1):5-34. Review.

PMID:
17004293
4.
5.

Challenges in developing a pediatric RSV vaccine.

Schickli JH, Dubovsky F, Tang RS.

Hum Vaccin. 2009 Sep;5(9):582-91. Epub 2009 Sep 28. Review.

6.

Pathogenesis of RSV lower respiratory tract infection: implications for vaccine development.

Brandenburg AH, Neijens HJ, Osterhaus AD.

Vaccine. 2001 Apr 6;19(20-22):2769-82. Review.

PMID:
11282187
7.

The role of dendritic cells in innate and adaptive immunity to respiratory syncytial virus, and implications for vaccine development.

Garg R, Shrivastava P, van Drunen Littel-van den Hurk S.

Expert Rev Vaccines. 2012 Dec;11(12):1441-57. doi: 10.1586/erv.12.117. Review.

PMID:
23252388
8.

Current progress on development of respiratory syncytial virus vaccine.

Chang J.

BMB Rep. 2011 Apr;44(4):232-7. doi: DOI 10.5483/BMBRep.2011.44.4.232. Review.

9.

Subunit and virus-like particle vaccine approaches for respiratory syncytial virus.

Morrison TG, Walsh EE.

Curr Top Microbiol Immunol. 2013;372:285-306. doi: 10.1007/978-3-642-38919-1_14. Review.

PMID:
24362695
10.

Advances in and the potential of vaccines for respiratory syncytial virus.

Jorquera PA, Oakley KE, Tripp RA.

Expert Rev Respir Med. 2013 Aug;7(4):411-27. doi: 10.1586/17476348.2013.814409. Review.

PMID:
23964629
11.

Clinical experience with respiratory syncytial virus vaccines.

Piedra PA.

Pediatr Infect Dis J. 2003 Feb;22(2 Suppl):S94-9. Review.

PMID:
12671459
13.

Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease.

Castilow EM, Olson MR, Varga SM.

Immunol Res. 2007;39(1-3):225-39. Review.

PMID:
17917067
14.

An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children.

Nair H, Verma VR, Theodoratou E, Zgaga L, Huda T, Simões EA, Wright PF, Rudan I, Campbell H.

BMC Public Health. 2011 Apr 13;11 Suppl 3:S30. doi: 10.1186/1471-2458-11-S3-S30. Review.

15.

Influenza and respiratory syncytial virus (RSV) vaccines for infants: safety, immunogenicity, and efficacy.

Beeler JA, Eichelberger MC.

Microb Pathog. 2013 Feb;55:9-15. doi: 10.1016/j.micpath.2012.11.013. Epub 2012 Dec 13. Review.

PMID:
23247146
16.

Respiratory syncytial virus vaccines: can we improve on nature?

Tristram DA, Welliver RC.

Pediatr Ann. 1993 Dec;22(12):715-8. Review.

PMID:
8139872
17.

Gene-based vaccine approaches for respiratory syncytial virus.

Loomis RJ, Johnson PR.

Curr Top Microbiol Immunol. 2013;372:307-24. doi: 10.1007/978-3-642-38919-1_15. Review.

PMID:
24362696
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk